NCT02716532View on ClinicalTrials.gov

Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 17, 2017

Study Completion Date

November 15, 2017

Conditions
Injuries, Acute BrainSevere Trauma Brain Injury (sTBI)Subarachnoid Hemorrhage, Aneurysmal
Interventions
DIETARY_SUPPLEMENT

Peptamen AF

Each patient will receive Peptamen AF throughout the trial.

Trial Locations (1)

1011

Department of Intensive Care Medicine CHUV, Lausanne

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT02716532 - Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI) | Biotech Hunter | Biotech Hunter